摘要
垂体腺瘤(Pitutary abenomas,PA)是一种较为常见的生长缓慢的颅内肿瘤,在颅内肿瘤中仅次于脑胶质瘤和脑膜瘤,约占10%,但尸检发现率为20%~30%,近年有增多趋势。由于影像学及内分泌检查手段和显微外科的进展,PA诊断和治疗水平均有了明显提高,手术并发症和死亡率明显下降。
参考文献20
-
1任祖渊.垂体腺瘤[A].王忠诚主编.神经外科学[J].武汉:湖北科学技术出版社,1998.518-519. 被引量:12
-
2Black PM, Zervas NT, Candia GL. Incidence and management of complication of transsphenoidal operation for pituitary adenomas. Neurosurgery, 1987 , 20 : 920. 被引量:1
-
3Laws ER Jr. Surgical management of pituitary adenomas.Curr Probl Cancer, 1984,8: 1. 被引量:1
-
4关树森,于春江,朱安林,江涛.额下经蝶入路显微手术切除鞍区肿瘤20例报告[J].中华神经外科杂志,1999,15(5):304-306. 被引量:37
-
5张纪.垂体瘤手术.见段国升,朱诚主编.手术学全集神经外科卷.北京:人民军区出版社,1994.132~138. 被引量:1
-
6Goel A.Nadkrni T. Surgical management of giant pituitary tumors-a review of 30 casses. Acta Neurochlr Wien, 1996,138 : 1042. 被引量:1
-
7Black PM, Zervas NT,Candia G. Management of large pituitary adenomas by transsphenoidal surgery. Surg Neurol,1988,29:443. 被引量:1
-
8Saito K ,Kuwayama A, Yamamoto N ,et al. The transsphenoidal removal of noufunctioning pituitary adenomas with suprasellar extenslons,the open sella method and intentionally staged operation. Neurosurgery, 1995,86 : 668. 被引量:1
-
9章翔,顾建文,费舟,付洛安,张剑宁,易声禹,张志文,刘卫平,王占祥,贺晓生,杨利孙,宋少军,陈义军.大型垂体腺瘤经蝶显微外科治疗原则与技术[J].中国临床神经外科杂志,1999,4(4):19-20. 被引量:9
-
10Partington MD,Davis DH,Laws ER,et al. Pituitary adenomas in childhood and adolescence. Results of transsphenoidal surgery. J Neurosurg, 1994,80: 209. 被引量:1
二级参考文献5
-
1唐懿芳,钟达夫.主成分分析方法对数据进行预处理[J].广西师范大学学报(哲学社会科学版),2002,38(S1):223-225. 被引量:16
-
2张成 张庆林 等.经额-蝶入路显微行垂体瘤全切除[J].中华神经精神外科杂志,1981,14:197-200. 被引量:1
-
3张成,中华神经外科杂志,1981年,14卷,197页 被引量:1
-
4王忠诚,神经外科学.颅内肿瘤,1979年,294页 被引量:1
-
5Dr. A. Goel,T. Nadkarni. Surgical management of giant pituitary tumours — A review of 30 cases[J] 1996,Acta Neurochirurgica(9):1042~1049 被引量:1
共引文献100
-
1李邦安,陶翔玉.垂体瘤卒中的诊疗6例病例分析[J].河南外科学杂志,2010,16(4):7-9.
-
2王国良,蔡加宁,李天栋,涂兰波,李建亭.大型鞍区肿瘤的眶上锁孔开颅显微手术治疗[J].中国神经肿瘤杂志,2003,1(4):226-229. 被引量:2
-
3魏宇魁,张波,王任直.垂体卒中[J].神经疾病与精神卫生,2004,4(3):165-167. 被引量:3
-
4王峻,吕华容,胡胜,吴星,周滨音.急性型垂体瘤卒中的诊断和治疗[J].时珍国医国药,2004,15(7):463-464. 被引量:1
-
5汪晓英,俞建波,童鹰.女性垂体腺瘤的临床特征及诊治[J].浙江医学,2004,26(10):767-769. 被引量:4
-
6王世波,韩静,潘隆盛,许百男,魏少波.垂体腺瘤卒中相关行为及生物学危险因素:Logistic多元回归分析[J].中国临床康复,2004,8(31):6936-6938. 被引量:5
-
7张华楸,舒凯,董芳永,汤浩,李龄,雷霆.垂体瘤卒中的MRI表现和临床对照研究[J].华中科技大学学报(医学版),2004,33(6):749-751. 被引量:19
-
8李家亮,于春江.急性垂体腺瘤卒中的临床研究[J].中华神经外科杂志,2005,21(1):35-38. 被引量:13
-
9单峤.显微外科手术治疗颅咽管瘤23例[J].实用儿科临床杂志,2005,20(1):89-90.
-
10周国胜,张新中.鞍区肿瘤的显微手术治疗进展[J].新乡医学院学报,2005,22(2):174-176. 被引量:1
同被引文献17
-
1Madonna D,Kendler A,Soliman AM.Ectopic growth hormonese creting pituitary adenoma in the sphenoid sinus[J].Ann Otol Rhinol Laryngol,2001,110(1):99-101. 被引量:1
-
2Ravichandran TP,Bakshi R,Heffner RR,et al.Aggressive giant pituitary adenoma presenting as a nasopharyngeal mass:magnetic resonance imaging and pathologic findings[J].J Neurooneol,2009,41(1):71-75. 被引量:1
-
3Yaniv E, Roppaport ZH. Endoscopic transeptal transsphenoidal surgery for pituitary tumors [J]. Neurosurgery, 1997;40(5): 944-946. 被引量:1
-
4Patel YC, Shereen E, Chick CL, et al. Guidelines for the diagnosis and treatment of acromegaly: a Canadian perspective [J]. Clin Invest Med, 2000; 23(3): 172-187. 被引量:1
-
5Racine MS, Barkan AL. Medical management of growth hormone-secreting pituitary adenomas [J]. Pituitary, 2002; 5(2): 67-76. 被引量:1
-
6Abs R, Verhelst J, Dominique M, et al. Cabergoline in the treatment of acromegaly: a study in 64 patients [J]. J Clin Endocrinol Metab, 1998; 83(2): 374-378. 被引量:1
-
7Rocheville M, La nge DC, Kumar U, et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity [J]. Science, 2000; 288(5463): 154-157. 被引量:1
-
8Marzullo P, Ferone D, Di Somma C, et al. Efficacy of combined treatment with lanreotide and cabergoline in selected therapy resistant acromegalic patients [J]. Pituitary, 1999; 1(2): 115-120. 被引量:1
-
9Parkinson C, Trainer PJ. Growth hormone receptor antagonists: therapy for acromegaly [J]. Bailliers Best Pract Res Clin Endocrinol Metab, 1999; 13(3): 419-430. 被引量:1
-
10van der Lely AJ, Hutson KR, Traniner PJ, et al. Long-term treatment of acromegaly with pegvisomant, a growth hormone-receptor antagonist [J]. Lancet, 2001; 358(9295): 1754-1759. 被引量:1
引证文献3
-
1张正善,丁学华.垂体生长激素腺瘤的治疗进展[J].中国微侵袭神经外科杂志,2005,10(5):233-235.
-
2荆彦平,张焱,胡瑛,王岸飞,王晓艳.蝶窦异位垂体生长激素腺瘤一例[J].放射学实践,2012,27(1):107-108. 被引量:4
-
3刘琦,田少斌,陈劲松.经鼻蝶入路切除垂体腺瘤术后并发症的处理[J].现代仪器与医疗,2018,24(1):34-35. 被引量:2
二级引证文献6
-
1卢琳,顾锋,陆召麟,付勇,姚勇,窦万臣,王任直,邢小平.异位促肾上腺皮质激素垂体腺瘤三例并文献复习[J].中华神经外科杂志,2012,28(9):914-917. 被引量:3
-
2陈聪,毛伟玉,侯波,有慧,苏长保,王任直,冯逢.异位垂体腺瘤的磁共振成像表现[J].中华神经外科杂志,2015,31(10):1007-1010. 被引量:5
-
3迟海燕,宋明强.异位生长激素分泌垂体瘤国内外文献分析[J].中华内分泌外科杂志,2017,11(6):521-524.
-
4冯若涵,刘含秋,卓丽华,魏雪梅.Rathke囊肿合并向蝶窦内生长的GH垂体腺瘤1例并文献复习[J].四川医学,2018,39(11):1303-1305. 被引量:1
-
5张铭兰.经颅、经蝶分期手术治疗巨大垂体腺瘤的应用效果观察[J].医学理论与实践,2022,35(9):1499-1500.
-
6代美丽.PDCA管理模式在经鼻蝶入路垂体瘤切除术患者中的护理效果[J].中国民康医学,2022,34(23):162-164. 被引量:1
-
1詹松.40例隆突性皮肤纤维肉瘤临床病理分析[J].广西医学,2006,28(4):589-590.
-
2邱雪松.不同年龄段女性乳腺癌患者临床病理特征分析[J].深圳中西医结合杂志,2017,27(5):92-93. 被引量:3
-
3曹亚昭,程书权.乙型肝炎合并肝脏巨大腺瘤1例[J].世界华人消化杂志,2017,25(14):1316-1320. 被引量:1
-
4刘小梅,张诚霖,殷荣平,郑曦晨,房兆续,胡海天,王学祥.靶向VEGF siRNA联合5-FU对人乳腺癌MCF-7荷瘤裸鼠的作用[J].江苏医药,2017,43(10):681-684. 被引量:3
-
5宋丹,魏莉,吴家雪.核因子蛋白90敲减对肝癌细胞增殖影响及机制的研究[J].临床肿瘤学杂志,2017,22(5):385-390.